POM-V Prescription Required

Inflacam 20 mg/ml Solution for Injection for Cattle, Pigs and Horses

Active ingredient: Meloxicam

Form

Injection

Species

Cattle Horses Pigs

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/5013

What it's used for

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating catt...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Inflacam 20 mg/ml Solution for Injection for Cattle, Pigs and Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical
signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic
therapy.
For the relief of post-operative pain following dehorning in calves.
Pigs
For use in non-infectious locomotor disorders to reduce the symptoms of lameness
and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia
(mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.
Horses
For use in the alleviation of inflammation and relief of pain in both acute and chronic
musculo-skeletal disorders.
For the relief of pain associated with equine colic.

Intramuscular use (pigs).
Intravenous use (cattle, horses).
Cattle
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg
body weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or
with oral re-hydration therapy, as appropriate.
Pigs
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e.
2 ml/100 kg body weight) in combination with antibiotic therapy, as appropriate. If
required, a second administration of meloxicam can be given after 24 hours.
Horses
Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e.
3 ml/100 kg body weight).
For use in the alleviation of inflammation and the relief of pain in both acute and chronic
musculo – skeletal disorders, Inflacam 15 mg/ml oral suspension may be used for
continuation of treatment at a dosage of 0.6 mg meloxicam/kg body weight, 24 hours
after administration of the injection.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
The use of suitably calibrated measuring equipment is recommended.
Avoid introduction of contamination during use.

Do not use in horses less than 6 weeks of age.
Do not use in animals suffering from impaired hepatic, cardiac or renal function and
haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
For the treatment of diarrhoea in cattle, do not use in animals of less than one week
of age.
See also section 3.7.

Cattle:
Common
(more than 1 but less than 10 animals in 100 animals
treated):
Injection site swelling
Very rare
(<1 animal / 10,000 animals treated, including
isolated reports):
Anaphylactoid reaction
.
Slight and transient following subcutaneous administration
May be serious (including fatal). If such reaction occurs, it should be treated
symptomatically.
Pigs:
Very rare
(<1 animal / 10,000 animals treated, including
isolated reports):
Anaphylactoid reaction
.
May be serious (including fatal). If such reaction occurs, it should be treated
symptomatically
Horses:
Very rare
(<1 animal / 10,000 animals treated, including
isolated reports):
Anaphylactoid reaction
.
Undetermined frequency
(cannot be estimated from the available data):
Injection site swelling
1
May be serious (including fatal). If such reaction occurs, it should be treated
symptomatically.
Transient, that resolves without intervention.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See also the package leaflet for
respective contact details.

None.

Special precautions for safe use in the target species:
Treatment of calves with the veterinary medicinal product 20 minutes before dehorning
reduces post-operative pain. The veterinary medicinal product alone will not provide
adequate pain relief during the dehorning procedure. To obtain adequate pain relief
during surgery co-medication with an appropriate analgesic is needed.
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which
require parenteral rehydration, as there may be a potential risk of renal toxicity.
In case of inadequate relief of pain when used in the treatment of equine colic, careful
re-evaluation of the diagnosis should be made as this could indicate the need for
surgical intervention.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Accidental self-injection may give rise to pain.
People with known hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)
should avoid contact with the veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.

Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-
inflammatory drugs or with anti-coagulant agents.

This veterinary medicinal product does not require any special storage conditions.

Cattle
Meat and offal: 15 days.
Milk: 5 days.
Pigs
Meat and offal: 5 days.
Horses
Meat and offal: 5 days.
Not authorised for use in horses producing milk for human consumption.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.